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Significant insight into the mechanisms involved in chronic heart failure (CHF) have been
provided by Schultz and his associates at the University of Nebraska Medical Center
with the use of pacing-induced heart failure rabbits. Critical among the CHF mechanisms
was the role of the carotid body (CB). The stimulated CB produces a wide array of
systemic reflex responses; certainly those in the cardiopulmonary (CP) system are the
most important in CHF. This generates a question as to whether the CB could serve as a
target for some kind of treatment to reestablish control of cardiorespiratory balance in CHF.
Any treatment would have to be based on a solid understanding of the mechanisms of
chemosensing by the CB as well as the transducing of that sensing into neural activity sent
to the medullary centers and regions of autonomic outflow to the periphery. Two avenues
of treatment could be to (1) silence or attenuate the CB’s neural output pharmacologically
and (2) excise the CBS. There is a long history of CB removal mostly as a remedy for
chronic obstructive lung disease. Results have been inconclusive as to the effectiveness
of this procedure. But if carefully planned, the procedure might be a helpful treatment.
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BASIC BACKGROUND
The stimulated carotid body (CB) provokes a wide array of car-
diopulmonary (CP) reflex responses, as well as having an impact
on the endocrine and renal systems (Figure 1).
This bilateral rate-sensitive interoreceptor, arguably the most
essential for maintaining normal homeostasis in the organism,
is located at the bifurcation of the common carotid artery into
the internal carotid artery (going to the Circle of Willis in the
brain) and the external carotid artery which perfuses the face and
scalp. The CBs are perfused at a very high rate by a branch of
the external carotid artery. Neural output from the CB is gen-
erated by excitatory neurotransmitters, released from the CB’s
thousands of glomus cells. They attach to receptors on abutting
neurons (branches of the glossopharyngeal nerve) the cell bodies
of which lie in the petrosal ganglion from which the traffic pro-
ceeds to the Nucleus Tractus Solitarii (NTS) in the brainstems’s
medulla. The neural traffic is increased in response to decreased
partial pressure of oxygen in arterial blood(PaO2), low glucose,
elevated levels of CO2 (PaCO2), elevated H+ levels [H+]a. Neural
output also increases in response to increases in temperature and
osmolarity.
ACTIVITY IN HEART DISEASE
Well-documented in animal models is the fact that chronic heart
failure (CHF) renders the CB more sensitive (Sun et al., 1999).
This increased sensitivity produces an increase in the CB’s neu-
ral output even under normal acid-base conditions; part of
this increase proceeds through NTS to the paramedian reticu-
lar nuclei, one seat of sympathetic neural outflow to the heart
and vessels, as well as to the location of modulating serotinergic
action. Increased sympathetic outflow to the ventricles is unde-
sirable in CHF since it can provoke ventricular arrhythmias
(Paterson, 2005).
ELEMENTS OF CHEMOSENSING AND
CHEMOTRANSDUCTION
Targeting the CBs as loci of treatment to see if homeostatic bal-
ance can be reestablished during disease requires a relatively deep
understanding of themechanisms of chemosensation and chemo-
transduction. In other words one must know how the CBs sense
the stimuli which depolarize the glomus cells, and what are the
mechanisms for converting this sensing into neural traffic.
The CB’s chemosensitive structure initiating depolarization of
the glomus cell is still under study though significant progress has
been made.
By way of a brief overview, heme-oxygenase 2 has been pro-
posed as the precise molecule that acts to close the calcium-
sensitive K channel (aka the BK or maxi-K channel). But
NADPH-oxidase and AMP-activated protein kinase have also
received support for the depolarizing role. What must be kept
in mind is that this important initiating molecule may not be
the same in all species. For though heme-oxygenase 2 seems to
function in the role in rats, one study reports that in knock-
out mice the absence of heme-oxygenase 2 does not prevent
the hypoxia-induced release of catecholamines. That NADPH-
oxidase is involved has been supported by manipulations of some
of its genetic components; e.g., deletion of p47phox enhanced the
CB’s normal responses to hypoxia.
But since the sensing of hypoxia by the CB and by the pul-
monary arteries has seemed somewhat similar in the product
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FIGURE 1 | CB stimulation increases the listed variables in the
respiratory system. Stimulation increases some CV variables but
decreases pulmonary vascular resistance (PVR), bronchial vascular
resistance (BVR), ocular vascular resistance (OVR), and venous
capacitance. Note also the impact of CB stimulation on the
endocrine and renal systems.
(neural excitation and vasoconstriction), it is interesting to note
that the precise O2 sensor in the CB remains unclear (Gonzalez
et al., 1994; Lopez-Barneo, 2003). Whereas in pulmonary arte-
rial smooth muscle cells “the bulk of evidence suggests that the
primary sensor for hypoxic pulmonary vasoconstriction is the
mitochondrion in the smooth muscle cells, which increases pro-
duction of ROS during hypoxia. . . It is possible that secondary
sensor mechanisms, such as ROS production by sarcolemmal
NADPH oxidase, also contribute” (Sylvester et al., 2012).
K channels which are oxygen-sensitive have always been
thought to play the initiating role in the depolarization of the
transmitter-containing glomus cells. Additional to the KBK chan-
nel, reports include other K channels as being oxygen-sensitive:
TASK-like K, Kv4.1, Kv4.3 channels. These channels have always
been thought to play a necessary role. The chronological steps in
chemotransduction in the CBs are fairly well-known and agreed
upon. Indeed, many of the sub-cellular and molecular mech-
anisms of sensing and transducing chemical signals have been
worked out quite well, though more work needs to be done.
TREATMENT OF THE TARGET TO REDUCE ITS IMPACT
But on the basis of our present corpus of knowledge what can
be suggested by way of treating the CB as a target for rescu-
ing neural control of cardiorespiratory balance in disease? Two
techniques suggest themselves: (a) silencing the CBs; (b) CB
removal/extirpation/resection.
(a) Silencing (1) Dopamine is well-known to blunt the CB’s neu-
ral output in response to hypoxia. (2) NO is well-known to
reduce the CB’s output in response to hypoxia. And a set
of recent studies has shown that nNOS is reduced in CHF
rabbits, a situation which is reversed by the vectoring into
the CBs nNOS (Li et al., 2005). (3) A second agent reported
to reduce the release of ACh and ATP, two excitatory neu-
rotransmitters in the CBs of the cat, is Na2S, a precursor of
H2S (Fitzgerald et al., 2011); this agent seems to open ATP-
sensitive K channels in the cell membrane of the glomus
cells. With the outflow of K+ ions the glomus cells become
hyperpolarized, inhibiting the entry of Ca++ and subsequent
release of neurotransmitters from the vesicles in the glomus
cells. Cat CBs also tested positive for an H2S synthesizing
enzyme, cystathionine-β-synthase. In this age of nanotech-
nology loading microspheres with a pharmacological agent
or an enzyme and fixing a marker of some sort on the surface
of the sphere which would recognize the CB does not seem
overly ambitious. (4) Finally, CHF rabbits showed a reduc-
tion in CB blood flow. This condition would per se increase
CB neural output due to the high metabolic rate of the CB
lowering PO2 and elevating PCO2 in the CB. A program of
regular modest exercise has been shown to be an effective way
to increase CB blood flow (Li et al., 2008; Ding et al., 2011).
This has been tried clinically in some hospitals, and found to
be effective in attenuating symptoms of cardiac malfunction.
(b) Removal of the CBs could be another option. The literature
addressing this option is extensive, but, regrettably, not at all
conclusive. It describes results in several species. And there
are different results. But human diseases for which the pro-
cedure was performed were cerebral ischemia (constricted
common carotid arteries). This was treated with endarterec-
tomy which involved CB removal. Most other reports treat
CB removal as a treatment for asthma, COPD; none address
CHF. Usually CB removal involves the removal of the carotid
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sinus sensors of blood pressure as well. If CBs are removed,
do patients survive? This is, of course, the critical question.
Let us review briefly a few of the more extensive stud-
ies. Nakayama (1961) used glomectomy to treat childhood
asthma. Some of these patients were tested 30 years later and
still exhibited no response to hypoxia. Bilateral endarterec-
tomy in seven patients denervated carotid bodies (Wade
et al., 1970) creating a permanent hypoventilation and a
modest hypercapnia. In 57 cases of COPD unilateral glomec-
tomy Phillips and Kintner (1970) concluded the procedure
did not significantly alter the course of bronchospastic dis-
ease, based on a battery of pulmonary function tests 4 years
post-glomectomy. On the other hand Stullberg and Winn
(1989) reported an improvement in dyspnea in three men
who had undergone bilateral glomectomy to offset severe
COPD. All three, ages 57, 67, 69, died 6, 18, 36 months
post-surgery, but remained convinced of the efficacy of the
surgery even though there was no improvement in their
severe airflow limitations. Whipp and Ward (1992) made
a very careful quantitative study of a very large group of
COPD patients the day before and the day after the surgery.
No deaths were reported after a very selective removal of
only the CB. Great intersubject variability was noted; but
the changes in pulmonary function and blood gases were
not large. Perhaps the most widely experienced investigator
of bilateral carotid chemoreceptor extirpation is Yoshiyuki
Honda and his colleagues. They found that exercise hyper-
pnea decreased in patients after the procedure (Honda et al.,
1979a). In another study they found the procedure enhanced
hypoxic tachycardia (Honda et al., 1988) in eight subjects 25
years post-surgery. In 11 asthmatic patients with the bilateral
CB resection they reported some residual chemosensitivity
some 23 years post-surgery (Honda et al., 1979b). Honda
reviews these and studies in other animals (1992).
Based on the above overview the answer to the critical ques-
tion is “Yes, most patients do live after CB resection.” Hence, it
would seem that the procedure might be pursued. But perhaps
the 1989 advice of Severinghaus in addressing bronchospastic
patients might be followed (Severinghaus, 1989): They might be
helped “. . . by permanent administration of oxygen via transcu-
taneous tracheal catheter. A variety of pharmacologic agents can
minimize bronchospasm and infection and help clear secretions.
Home oxygen concentrators and portable liquid oxygen supplies
have become easily available to most patients. Only when all avail-
able methods fail to adequately relieve patients should surgical
intervention be considered.” He also encourages the study of the
procedure in a small group of carefully selected incapacitated
patients by the NIH.
So survival after glomectomy seems to be the most frequent
result, but the advantages of the procedure for better pulmonary
functioning still seems to be controversial. Nevertheless, return-
ing our focus to the advantage of glomectomy for cardiac prob-
lems, we see several more recent studies illustrating the central
role of the CB’s sensitivity in spontaneously hypertensive rats; the
CB’s discharge responses to hypoxia and hypercapnia are signif-
icantly greater than in normotensive rats (Fukuda et al., 1987).
Carotid body denervation (CBD) saw no rise in young SHR ani-
mals, or a drop in blood pressure in adults (Abdala et al., 2012).
Another rat study (Fletcher et al., 1992) reported how CBD elim-
inated the rise in blood pressure generated by chronic episodic
hypoxia, such as is found in sleep apnea. Ribeiro et al. (2013)
demonstrate how CBD prevents the development of insulin resis-
tance and hypertension induced by hypercaloric diets. The most
comprehensive animal study with which we are familiar is that of
Marcus and his colleagues in CHF rabbits (Marcus et al., 2014).
In brief, their study showed how CBD reduced sympathetic nerve
activity, disordered breathing patterns, arrhythmia incidence, and
sympatho-respiratory coupling in CHF rabbits. This should be
considered the “gold standard” among animal studies of the effect
of CBD as a focal point for rescuing neural control of cardiores-
piratory balance in disease. The relevance of these studies for
humans can be seen in an earlier study of patients with CHF, some
of whom had normal chemosensitivity and others suffered from
chemoreceptor hypersensitivity. The former group of 53 had a
3-year survival rate of 77%; the latter group of 27 had a rate of
41% (Ponikowski et al., 2001).
ACKNOWLEDGMENT
The author gratefully acknowledges the support of the NHLBI
award RO1—HL-50712-13.
REFERENCES
Abdala, A. P., McBryde, F. D., Marina, N., Hendy, E. B., Engelman, Z. J., Fudim,
M., et al. (2012). Hypertension is critically dependent on the carotid body
input in the spontaneously hypertensive rat. J. Physiol. 59017, 4269–4277. doi:
10.1113/jphysiol.2012.237800
Ding, Y., Li, Y.-L., and Schultz, H. D. (2011). Role of blood flow in carotid
body chemoreflex function in heart failure. J. Physiol. 589, 245–258. doi:
10.1113/jphysiol.2010.200584
Fitzgerald, R. S., Shirahata, M., Chang, I., Kostuk, E., and Kiihl, S. (2011).
The impact of hydrogen sulfide (H2S) on neurotransmitter release
from the cat carotid body. Respir. Physiol. Neurobiol. 176, 80–89. doi:
10.1016/j.resp.2011.01.010
Fletcher, E. C., Lesske, J., Behm, R., Miller, C. C. 3rd., Stauss, H., and Unger, T.
(1992). Carotid chemoreceptors, systemic blood pressure, and chronic episodic
hypoxia mimicking sleep apnea. J. Appl. Physiol. 72, 1978–1984.
Fukuda,Y., Sato, A., and Trzebski, A. (1987). Carotid chemoreceptor dis-
charge responses to hypoxia and hypercapnia in normotensive and sponta-
neously hypertensive rats. J. Auton. Nerv. Syst. 19, 1–84. doi: 10.1016/0165-
1838(87)90139-1
Gonzalez, C., Almaraz, L., Obeso, A., and Rigual, R. (1994). Carotid body chemore-
ceptors: From natural stimuli to sensory discharges. Physiol. Rev. 74, 829–898.
Honda, Y. (1992). Respiratory and circulatory activities in carotid body-resected
humans. J. Appl. Physiol. 73, 1–8.
Honda, Y., Hashizume, I., Kimura, H., and Severinghaus, J. W. (1988). Bilateral
carotid body resection in man enhances hypoxic tachycardia. Jap. J. Physiol. 38,
917–928. doi: 10.2170/jjphysiol.38.917
Honda, Y., Myojo, S., Hasegawa, S., Hasegawa, T., and Severinghaus, J. W.
(1979a). Decreased exercise hyperpnea in patients with bilateral carotid
chemoreceptor resection. J. Appl. Physiol. Respirat. Environ. Exerc. Physiol. 46,
908–912.
Honda, Y., Watanabe, S., Hashizume, I., Satomura, Y., Hata, N., Sakakibara, Y.,
et al. (1979b). Hypoxic chemosensitivity in asthmatic patients two decades after
carotid body resection. J. Appl. Physiol. Respirat. Environ. Exerc. Physiol. 46,
632–638.
Li, Y. L., Ding, Y., Agnew, C., and Schultz, H. D. (2008). Exercise training improves
peripheral chemoreflex function in heart failure rabbits. J. Appl. Physiol. 105,
782–790. doi: 10.1152/japplphysiol.90533.2008
Li, Y.-L., Li, Y.-F., Liu, D., Cornish, K. G., Patel, K. P., Zucker, I. H.,
et al. (2005). Gene transfer of nNOS to carotid body reverses enhanced
www.frontiersin.org August 2014 | Volume 5 | Article 304 | 3
Fitzgerald Carotid body rescues neural control
chemoreceptor function in heart failure rabbits. Circ. Res. 97, 260–267. doi:
10.1161/01.RES.0000175722.21555.55
Lopez-Barneo, J. (2003). Oxygen and glucose sensing by carotid body glo-
mus cells. Curr. Opin. Neurobiol. 13, 493–499. doi: 10.1016/S0959-4388(03)
00093-X
Marcus, N. J., Del Rio, R., Schultz, E. P., Xia, S.-H., and Schultz, H. D. (2014).
Carotid body denervation improves autonomic and cardiac function and atten-
uates disordered breathing in congestive heart failure. J. Physiol. 592, 391–408.
doi: 10.1113/jphysiol.2013.266221
Nakayama, K. (1961). Surgical removal of the carotid body for
bronchial asthma. Dis. Chest 40, 595–604. doi: 10.1378/chest.
40.6.595
Paterson, D. J. (2005). Targeting arterial chemoreceptor over-activity in heart
failure with a gas. Circ. Res. 97, 201–203. doi: 10.1161/01.RES.0000177931.
10616.cb
Phillips, R. M., and Kintner, H. P. (1970). Results of glomectomy in chronic
obstructive pulmonary disease: a four year follow-up report of 57 cases. Chest
58, 358–362. doi: 10.1378/chest.58.4.358
Ponikowski, P., Chua,T. P., Anker, S. D., Francis, D. P., Doehner, W., Banasiak,
W., et al. (2001). Peripheral chemoreceptor hypersensitivity: an ominous
sign in patients with chronic heart failure. Circulation 104, 544–549. doi:
10.1161/hc3101.093699
Ribeiro, M. J., Sacramento, J. F., Gonzalez, C., Guarino, M. P., Monteiro, E. C.,
and Conde, S. V. (2013). Carotid body denervation prevents the development
of insulin resistance and hypertension induced by hypercaloric diets. Diabetes
62, 2905–2916. doi: 10.2337/db12-1463
Severinghaus, J.W. (1989). Carotid body resection for COPD?Chest 95, 1128–1129.
doi: 10.1378/chest.95.5.1128
Stullberg, M. S., and Winn, W. R. (1989). Bilateral carotid body resection for the
relief of dyspnea in severe chronic obstructive pulmonary disease. Chest 95,
1123–1128. doi: 10.1378/chest.95.5.1123
Sun, S. Y., Wang, W., Zucker, I. H., and Schultz, H. D. (1999). Enhanced peripheral
chemoreflex function in conscious rabbits with pacing-induced heart failure.
J. Appl. Physiol. 86, 1264–1272.
Sylvester, J. T., Shimoda, L. A., Aaronson, P. I., and Ward, J. P. T. (2012). Hypoxic
pulmonary vasoconstriction. Physiol. Rev. 92, 367–520. doi: 10.1152/phys-
rev.00041.2010
Wade, J. G., Larson, C. P. Jr., Hickey, R. F., Ehrenfeld, W. K., and Severinghaus,
J. W. (1970). Effect of carotid endarterectomy on carotid chemoreceptor
and baroreceptor function in man. N. Engl. J. Med. 282, 823–829. doi:
10.1056/NEJM197004092821501
Whipp, B. J., and Ward, S. A. (1992). Physiologic changes following bilateral
carotid body resection in patients with chronic obstructive pulmonary disease.
Chest 101, 656–661. doi: 10.1378/chest.101.3.656
Conflict of Interest Statement: The author declares that the research was con-
ducted in the absence of any commercial or financial relationships that could be
construed as a potential conflict of interest.
Received: 12 June 2014; paper pending published: 07 July 2014; accepted: 25 July 2014;
published online: 20 August 2014.
Citation: Fitzgerald RS (2014) Carotid body: a new target for rescuing neural con-
trol of cardiorespiratory balance in disease. Front. Physiol. 5:304. doi: 10.3389/fphys.
2014.00304
This article was submitted to Integrative Physiology, a section of the journal Frontiers
in Physiology.
Copyright © 2014 Fitzgerald. This is an open-access article distributed under the
terms of the Creative Commons Attribution License (CC BY). The use, distribution or
reproduction in other forums is permitted, provided the original author(s) or licensor
are credited and that the original publication in this journal is cited, in accordance with
accepted academic practice. No use, distribution or reproduction is permitted which
does not comply with these terms.
Frontiers in Physiology | Integrative Physiology August 2014 | Volume 5 | Article 304 | 4
